Home › NDC Lookup › RxCUI directory › RxCUI 2393587

Monomethyl fumarate 95 MG Delayed Release Oral Capsule — RxCUI 2393587

RxNorm drug concept · Semantic clinical drug
RxCUI 2393587 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2393587
Official nameMonomethyl fumarate 95 MG Delayed Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)114 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Monomethyl Fumarate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Bafiertam helps manage relapsing forms of MS — meaning the type where symptoms flare up and then ease off, at least partly. It's approved for relapsing-remitting MS, clinically iso...
  • What exactly does Bafiertam do for my MS?
  • Flushing — sudden redness, warmth, or tingling in your face and skin — is actually one of the most common side effects, reported by a significant number of people on this class of...
  • I've heard flushing is a big problem. Will that happen to me, and is there anything I can do about it?
📖 Read our full Monomethyl Fumarate guide →

🕸️ Concept Web — How Monomethyl fumarate 95 MG Delayed Release Oral C... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Monomethyl fumarate 95 MG Delayed Release Oral Capsule RxCUI 2393587

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Monomethyl fumarate 1546433
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Bafiertam 2393588
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Monomethyl fumarate Delayed Release Oral Capsule 2393586
    • Monomethyl fumarate Oral Product 2393584
    • Monomethyl fumarate Pill 2393585
    • Monomethyl fumarate Delayed Release Oral Capsule [Bafiertam] 2393590
    • Bafiertam Oral Product 2393591
    • Bafiertam Pill 2393592
    • Delayed Release Oral Capsule 316995
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Monomethyl fumarate 95 MG SCDC · 2393583
  • Monomethyl fumarate Delayed Release Oral Capsule SCDF · 2393586
  • Monomethyl fumarate Oral Product SCDG · 2393584
  • Monomethyl fumarate Pill SCDG · 2393585

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2393587 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
69387-0001-01 120 CAPSULE in 1 BOTTLE (69387-001-01) BAFIERTAM Banner Life Sciences LLC 2020-04-28
Observed labelers: Banner Life Sciences LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.